`Date Filed: Nov. 16, 2016
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`WOCKHARDT BIO AG,
`Petitioner,
`
`v.
`
`JANSSEN ONCOLOGY, INC.,
`Patent Owner.
`
`________________
`
`Case IPR2016-01582
`Patent 8,822,438
`
`________________
`
`
`
`MOTION TO SEAL UNDER 37 C.F.R. §§ 42.14 AND 42.54
`
`
`
`
`
`
`
`
`
`
`IPR2016-01582
`Patent 8,822,438
`
`
`Pursuant to 37 C.F.R. §§ 42.14 and 42.54, Patent Owner Janssen Oncology,
`
`Inc. (“Janssen”) respectfully submits this motion to seal the confidential versions
`
`of Janssen’s Preliminary Response as well as Exhibits 2002 and 2003. The Parties
`
`have met and conferred and agreed to a modified version of the Board’s Default
`
`Protective Order contained in Appendix B of the Patent Trial Practice Guide. (See
`
`Ex. 2006). Pursuant to paragraph 4(A)(ii) of the Parties’ proposed Standing
`
`Protective Order, Patent Owner is also concurrently filing non-confidential
`
`versions of Janssen’s Preliminary Response, and Exhibit 2002 (see non-
`
`confidential version at Exhibit 2005) and 2003 (see non-confidential version at
`
`Exhibit 2004) with the confidential portions redacted.
`
`I. Reasons for Sealing Certain Confidential Information
`
`Janssen’s Preliminary Response cites to material contained in Exhibits 2002
`
`and 2003. Exhibit 2002 is an email exchange between Vipin Dhanorkar, Vice
`
`President of Global IP at Wockhardt Bio AG, and Jennifer Reda, Assistant General
`
`Counsel at Johnson & Johnson. Exhibit 2003 is the declaration of Jennifer Reda.
`
`Exhibits 2002 and 2003 reflect information from business confidential
`
`communications between the parties. Because Exhibits 2002 and 2003 contain
`
`business confidential communications between the parties, Janssen believes that
`
`good cause exists to seal portions of Exhibits 2002 and 2003, and the portions of
`
`
`
`1
`
`
`
`
`IPR2016-01582
`Patent 8,822,438
`
`Janssen’s Preliminary Response disclosing confidential information from Exhibits
`
`2002 and 2003.
`
`II. Certification of Non-Publication Status
`
`With respect to Janssen’s Preliminary Response, and Exhibits 2002 and
`
`2003, Janssen’s undersigned counsel certify that the information contained therein
`
`and sought to be sealed has not, to the best of their knowledge, been published or
`
`otherwise made public.
`
`III. Certification of Conference of the Parties Pursuant to 37 C.F.R. §
`42.54
`
`The Parties have conferred in good faith via telephone and email and agreed
`
`to the terms of a modified version of the Board’s Default Protective Order. See Ex.
`
`2006.
`
`IV. Proposed Protective Order
`
`The Parties’ proposed Standing Protective Order submitted concurrently (see
`
`Ex. 2006) and to which the Parties have agreed to be bound in this matter, is a
`
`slightly modified version of the Board’s Default Protective Order. See Ex. 2007
`
`(redline comparison of proposed and default protective orders).
`
`***
`
`For the foregoing reasons, Patent Owner respectfully requests that the Board
`
`enter an Order sealing the confidential versions of Janssen’s Preliminary Response,
`
`2
`
`
`
`
`
`IPR2016-01582
`Patent 8,822,438
`
`and Exhibits 2002 and 2003, and requiring the parties to abide by the Standing
`
`Protective Order (See Ex. 2006).
`
`Dated: November 16, 2016
`
`Respectfully submitted,
`
`By: /Dianne B. Elderkin /
`Dianne B. Elderkin (Reg. No. 28,598)
`Barbara L. Mullin (Reg. No. 38,250)
`Ruben H. Munoz (Reg. No. 66,998)
`AKIN GUMP STRAUSS HAUER
`& FELD LLP
`Two Commerce Square
`2001 Market Street, Suite 4100
`Philadelphia, PA 19103
`Tel: (215) 965-1200
`Fax: (215) 965-1210
`JANS-ZYTIGA@akingump.com
`
`
`
`
`
`
`David T. Pritikin (pro hac vice
`forthcoming)
`Bindu Donovan (pro hac vice
`forthcoming)
`S. Isaac Olson (pro hac vice
`forthcoming)
`SIDLEY AUSTIN LLP
`787 Seventh Avenue
`New York, NY 10019
`Tel.: (212) 839-5300
`Fax: (212) 839-5599
`ZytigaIPRTeam@sidley.com
`
`
`3
`
`
`
`
`
`IPR2016-01582
`Patent 8,822,438
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing MOTION TO
`
`SEAL UNDER 37 C.F.R. §§ 42.14 AND 42.54 was served on counsel of record
`
`on November 16, 2016 by filing this document through the End-to-End System, as
`
`well as delivering a copy via electronic mail to counsel of record for the Petitioner
`
`at the following addresses:
`
`Dennies Varughese - dvarughe-PTAB@skgf.com
`Deborah A. Sterling - dsterlin-PTAB@skgf.com
`Christopher M. Gallo - cgallo-PTAB@skgf.com
`
`Respectfully submitted,
`
`
`
`By: /s/ Dianne B. Elderkin
`Dianne B. Elderkin
`Registration No. 28,598
`
`Counsel for Patent Owner
`Janssen Oncology, Inc.
`
`
`
`Date: Nov. 16, 2016
`
`
`
`4